Incidence of uterine bleeding following oral anticoagulant use in Food and Drug Administration's Sentinel System

Am J Obstet Gynecol. 2021 Apr;224(4):403-404. doi: 10.1016/j.ajog.2020.11.034. Epub 2020 Nov 27.

¹ Division of Urology, Obstetrics and Gynecology, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993. Electronic address: abby.anderson@fda.hhs.gov.
² Division of Urology, Obstetrics and Gynecology, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993.
³ Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA.
⁴ Division of Pharmacoepidemiology, Office of Pharmacovigilance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
⁵ Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.

No abstract available

Publication types